Glucocorticoid-induced Osteoporosis

• FDA approval · 2008-06-25
  FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)

  FDA approved a supplemental application for teriparatide submitted by Prasco Laboratories.

• FDA approval · 2008-04-22
  FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)

  FDA approved a supplemental application for Actonel (risedronate sodium) submitted by Allergan, Inc., resulting in an approved update to the…

• FDA approval · 2008-02-28
  FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)

  FDA approved a supplemental application for teriparatide submitted by Prasco Laboratories.

• FDA approval · 2008-02-06
  FDA Approved: ALENDRONATE SODIUM — Original Application (Amneal Pharmaceuticals of New York LLC)

  FDA approved the original ANDA for Alendronate Sodium (generic) from Amneal Pharmaceuticals of New York LLC, expanding access for treatment …

• FDA approval · 2007-10-05
  FDA Approved: RISEDRONATE SODIUM — Original Application (Teva Pharmaceuticals USA, Inc.)

  FDA approves Teva's risendronate sodium generic from an Original Application (ANDA 077132), enabling marketing of a risendronate sodium tabl…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2007-04-16
  FDA Approved: RECLAST — Original Application (Sandoz Inc)

  FDA approves Sandoz's RECLAST (zoledronic acid) original application for osteoporosis-related indications, including postmenopausal osteopor…

• FDA approval · 2006-12-28
  FDA Approved: FOSAMAX — Supplemental Application (Organon LLC)

  FDA approved a supplemental application for Fosamax (alendronate sodium) submitted by Organon LLC.

• FDA approval · 2006-08-11
  FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)

  FDA approves a supplemental application for Actonel (risedronate sodium) from Allergan, Inc., indicating an approved update to its labeling/…